Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
28
29
30
31
1
2
3
5
6
7
8
9
10
13
14
15
16
17
18
12:00 AM - Epic UGM 2025
19
20
21
22
23
24
25
26
27
28
29
30
31
The 2025 DirectTrust Annual Conference
2025-08-04 - 2025-08-07    
12:00 am
Three of the most interesting healthcare topics are going to be featured at the DirectTrust Annual conference this year: Interoperability, Identity, and Cybersecurity. These are [...]
ALS Nexus Event Recap and Overview
2025-08-11 - 2025-08-14    
12:00 am
International Conference on Wearable Medical Devices and Sensors
2025-08-12    
12:00 am
Conference Details: International Conference on Wearable Medical Devices and Sensors , on 12th Aug 2025 at New York, New York, USA . The key intention [...]
Epic UGM 2025
2025-08-18 - 2025-08-21    
12:00 am
The largest gathering of Epic Users at the Epic user conference in Verona. Generally highlighted by Epic’s keynote where she often makes big announcements about [...]
Events on 2025-08-04
Events on 2025-08-11
Events on 2025-08-18
Epic UGM 2025
18 Aug 25
Verona
Articles

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

amyotrophic lateral scelrosis

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

Amyotrophic lateral sclerosis (ALS) belongs to a group of neurological disease. Otherwise called motor neuron diseases, they influence the engine elements of voluntary muscles in the body. Factors, for example, an expansion in the occurrence rate of ALS, grow in the awareness about the ailment among patients, and ascend in the geriatric populace is relied upon to help the development of the amyotrophic lateral sclerosis market. Other factors including the tendency towards the stationary way of life are driving the market development and expanding the danger of getting attacked by ALS.

Furthermore, the expanding geriatric populace substantiates market development, making interest in symptomatic and focused on treatment alternatives. However, the staggering expense of the treatment of ALS may impede market development over the figure time frame.

The Amyotrophic lateral sclerosis market is growing at 7.89 % CAGR and is expected to reach the valuation of USD 841.6 million by the year 2023.

Major players

Mylan N.V. (U.S.), Covis Pharma (Switzerland), Ionis Pharmaceutical (U.S.), ITF Pharma (U.S.), Ascend Pharmaceuticals LLC (U.S.), Apotex Inc. (Canada), Sun Pharmaceutical (India), Mitsubishi Tanabe Pharma America (U.S.), Biogen (U.S.), Sanofi (France), among others are some of the major players in the Global amyotrophic lateral sclerosis market.

The Global amyotrophic lateral sclerosis market has been classified on the basis of its treatment, type, end-user, and regional demand. Based on its type, the market is classified into familial ALS and sporadic. Based on its treatment, the market has been segmented into physical therapy, speech therapy, medication, respiratory therapy, and others. By its end-user, the ALS market has been segmented into research & academic institutes, specialty centers, hospitals, and others.

Source inforgrowth.com/report/1850367/amyotrophic-lateral-sclerosis-market

About InForGrowth

At InForGrowth, Understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable and trusted publishing partners, we are paving way for a more simplified and relevant research.